Silencing of <i>ISLR</i> inhibits tumour progression and glycolysis by inactivating the IL‑6/JAK/STAT3 pathway in non‑small cell lung cancer
Peng Zhang(Zhejiang Hospital), Guangming Yang(Nanjing Tech University)
Cited by 22
Related Papers
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics
|Nucleic Acids Research|2017|551
Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery
|Nucleic Acids Research|2011|485
NPASS: natural product activity and species source database for natural product research, discovery and tool development
|Nucleic Acids Research|2017|266
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
|Science Translational Medicine|2021|237